Audit 4 Chuan Kelun Pharmaceutical Co., Ltd. IPO. To understand the relevant circumstances, the reporter then contacted a spokesman Collen Pharmaceutical single Xie Meng. However, single Xie Meng said the company is in pre-IPO quiet period, is not convenient for comment.
Koren medicine production base is located in the main of city and. It is understood that Koren The shares to be issued 6000, planning and fund-raising 1.491 billion yuan, is expected to issue price of 24.85 yuan per share. Financial data, Cologne in 2009 earnings per share of 2.38 yuan, net assets of 8.77 yuan per share.
Koren Pharmaceutical Innovation Liu was named head of the Sichuan Economy Person of the Year in 2009. Koren medicine for 3 consecutive tax years, private enterprises to enter China ranks 100, with an annual output of 2.6 billion bottles (bags) of the outstanding performance of the world's largest specialized manufacturer of infusion. Koren's family business a strong flavor, innovation and family members Liu Liu Sui Hua, LIU Ya, Ya-Shu, Liu Weihua, Yin Fenggang, are holding shares of the Company. The issue, Mrs innovation holds 6193.73 million shares, of the total equity of 34.41%; the Liu family, six members of the total shares held by 9525.45, the total share capital of 52.91%. To issue price of 24.85 yuan, Liu innovative family is sitting on nearly 2.4 billion fortune.
It is understood that New Hope Group in March 25, 2008 price of 40 yuan per share capital increase Cologne medicine, was 225 million shares; the same year on March 31, Cologne to the capital reserve capitalization, 10 shares to all shareholders increase by transferring 1.25 per share, the number of shares held by New Hope Group, to 506.25 million shares, 2.81% of total share capital.
Transfusion products in the domestic market, Double-Crane Pharmaceutical and medicine are each other's main rivals Cologne. Double-Crane Pharmaceutical early in 1997, has achieved market, while Cologne is very tortuous path to market. In 2005, the Cologne For backdoor listing, after the company's ownership structure does not meet due to the listing requirements but have not been successful; in 2006, Cologne and Shanghai Century venture capital firm contact, attempting to use the Shanghai Century shell resources in the United States to achieve listing. By the end of May 2007, Shanghai Century announced the signing of certainty with Koren share purchase agreement to acquire 100% stake in Cologne medicine. After the acquisition, Shanghai Century Pharmaceutical Co., Ltd. changed its name to China Cologne. As the merger has not been relevant approval, in January 2008, the Shanghai Century and Koren's "marriage" come to an end
Washed off the A shares are listed on Cologne third time planning. It is reported that Koren has passed the preliminary investment over Environmental protection Department of environmental audits, issuance examination committee next week now and so the audit result. I am China home garden manufacturers writer, reports some information about toaster pizza oven , delonghi stand mixer.
Related Articles -
toaster pizza oven, delonghi stand mixer,
|
